Fortis Healthcare · NSE: FORTIS · BSE: 532843

Q2 FY21 results · Jul–Sep 2020

Fortis Healthcare reported revenue from operations of ₹994.70 crore (down 17.9% from Q2 FY20) and net profit of ₹15.47 crore (down 87.5% from Q2 FY20) for Q2 FY21 (Jul–Sep 2020), on a consolidated basis.

Consolidated · ₹ crore
Item	Q2 FY21	Q2 FY20	YoY	Q1 FY21	QoQ
Revenue from operations	994.70	1,212.17	−17.9%	605.95	+64.2%
Other income	25.60	9.75	+162.6%	4.45	+475.3%
Total income	1,020.30	1,221.92	−16.5%	610.40	+67.2%
Profit before share of associates & JVs and tax	29.80	126.59	−76.5%	(211.12)	Turned profit
Share of profit/(loss) of associates & JVs	8.25	3.16		2.86
Net profit for the period	15.47	124.04	−87.5%	(187.88)	Turned profit
Attributable to shareholders of the company	(3.91)	110.98	Turned loss	(178.92)	Loss narrowed
EPS, basic (₹)	(0.05)	1.47	Turned loss	(2.37)	Loss narrowed
Net margin (%)	1.6	10.2		-31.0

This company reports a share of profit/(loss) from associates and joint ventures. BSE’s filing format records that share after tax, so it is shown on its own line. The company’s own statement may add it before its “profit before tax” line.

Standalone · ₹ crore
Item	Q2 FY21	Q2 FY20	YoY	Q1 FY21	QoQ
Revenue from operations	153.13	181.40	−15.6%	100.56	+52.3%
Other income	54.50	147.99	−63.2%	53.55	+1.8%
Total income	207.63	329.39	−37.0%	154.11	+34.7%
Profit before tax	5.71	21.14	−73.0%	31.10	−81.6%
Net profit for the period	4.15	(13.27)	Turned profit	19.90	−79.1%
EPS, basic (₹)	0.06	(0.17)	Turned profit	0.26	−76.9%
Net margin (%)	2.7	-7.3		19.8

Consolidated

Filed with BSE: 13 Nov 2020, 15:57 IST
Board meeting: 12 Nov 2020
Period: 01 Jul 2020 to 30 Sep 2020
Review status: Unaudited
Source: XBRL filing on BSE

Standalone

Filed with BSE: 13 Nov 2020, 15:57 IST
Board meeting: 12 Nov 2020
Period: 01 Jul 2020 to 30 Sep 2020
Review status: Unaudited
Source: XBRL filing on BSE